How should I interpret iron studies showing serum iron 79 µg/dL, total iron‑binding capacity (TIBC) 272 µg/dL, transferrin saturation 29 %, and ferritin 243 ng/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Iron Studies Interpretation: Mildly Elevated Ferritin with Otherwise Normal Parameters

Your iron studies show mildly elevated ferritin (243 ng/mL) in the setting of normal serum iron, TIBC, and transferrin saturation—this pattern does NOT indicate iron deficiency and most likely reflects either inflammation, chronic disease, or normal variation rather than iron overload.

Key Findings Analysis

Your results show:

  • Serum iron: 79 µg/dL (normal range 45-160) - within normal limits
  • TIBC: 272 µg/dL (normal range 250-450) - within normal limits
  • Transferrin saturation: 29% (normal range 16-45%) - within normal limits
  • Ferritin: 243 ng/mL (normal range 16-232) - mildly elevated

Clinical Interpretation

You Do NOT Have Iron Deficiency

Iron deficiency would require ferritin <45 ng/mL for optimal sensitivity 1, or at minimum <15 ng/mL for high specificity 2. Your ferritin of 243 ng/mL essentially excludes iron deficiency, even in the presence of inflammation 2. The British Society of Gastroenterology guidelines note that ferritin >150 ng/mL is "unlikely to occur with absolute iron deficiency, even in the presence of inflammation" 2.

Your normal transferrin saturation (29%) further confirms adequate iron availability for erythropoiesis. Research demonstrates that serum iron and TIBC provide limited additional diagnostic value when ferritin is available 3, but in your case, all parameters align to exclude iron deficiency.

The Mildly Elevated Ferritin

Ferritin is an acute-phase reactant that rises with:

  • Inflammation or infection (most common cause of mild elevation)
  • Chronic liver disease
  • Metabolic syndrome
  • Malignancy
  • Normal biological variation (your level is only marginally above the upper limit)

A ferritin of 243 ng/mL represents only mild elevation and does NOT suggest clinically significant iron overload, which typically requires ferritin >1000 ng/mL with elevated transferrin saturation (>45-50%).

What You Should Do

No Iron Supplementation Needed

Do not take iron supplements—you have adequate iron stores and supplementation could be harmful.

Evaluate for Underlying Causes

Look for:

  • Recent or ongoing infections
  • Inflammatory conditions (arthritis, inflammatory bowel disease)
  • Liver disease (check liver enzymes if not recently done)
  • Metabolic syndrome markers (glucose, lipids, BMI)
  • Alcohol use history

Follow-Up Strategy

  • If asymptomatic with no concerning findings: Repeat ferritin in 3-6 months to assess trend
  • If ferritin continues rising or exceeds 300 ng/mL: Consider hepatitis panel, liver imaging, and evaluation for hereditary hemochromatosis (though your normal transferrin saturation makes this unlikely)
  • If inflammatory condition identified: Treat underlying condition; ferritin should normalize

Common Pitfalls to Avoid

Do not pursue gastrointestinal evaluation for iron deficiency—you don't have iron deficiency. The AGA guidelines recommending bidirectional endoscopy apply only to patients with confirmed iron deficiency anemia (ferritin <45 ng/mL) 1, which you clearly do not have.

Do not interpret this as iron overload requiring phlebotomy or chelation—iron overload requires both elevated ferritin AND elevated transferrin saturation (typically >45%), which you lack.

References

3
Research

Diagnostic Accuracy of Serum Iron and Total Iron Binding Capacity (TIBC) in Iron Deficiency State.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016

Related Questions

Given a patient with ferritin 10 ng/mL, serum iron 36 µg/dL, total iron‑binding capacity (TIBC) 445 µg/dL, transferrin saturation 8 %, and unsaturated iron‑binding capacity (UBC) 409 µg/dL, what medication should be started?
In a 28-year-old male with ferritin 482 µg/L, serum iron 82 µg/dL, unsaturated iron‑binding capacity (UIBC) 189 µg/dL, total iron‑binding capacity (TIBC) 271 µg/dL, and iron saturation 30%, what is the most likely explanation and recommended next steps?
With a ferritin of 26 ng/mL, low‑normal serum iron, high total iron‑binding capacity, low transferrin saturation, and elevated unsaturated iron‑binding capacity, what is the diagnosis and recommended next steps for evaluation and treatment?
In an 86‑year‑old male with ferritin 585 ng/mL, serum iron 45 µg/dL, total iron‑binding capacity (TIBC) 274 µg/dL, transferrin saturation 16 %, hemoglobin 13.3 g/dL, and alkaline phosphatase 165 U/L, what is the most likely diagnosis and appropriate management?
In a 52-year-old female with ferritin 135 µg/L, total iron‑binding capacity 264 µg/dL, and transferrin saturation 43 % who is not taking iron supplements, should she be started on iron therapy?
What is the appropriate management of severe leg edema in a patient with chronic kidney disease?
In a 37-year-old woman presenting to the emergency department with fever, frontoparietal headache, leukocytosis with neutrophil predominance, and no nuchal rigidity, focal neurological deficits, or papilledema, what is the appropriate immediate work‑up and empiric treatment for possible bacterial meningitis?
Why should I continue systemic immunosuppressive therapy for sarcoidosis in a patient who had granulomas surgically removed and whose chest computed tomography (CT) and X‑ray have been normal for several years?
In a patient with low vitamin D, markedly elevated anti‑dsDNA, normal anti‑CCP IgG, and elevated total T4 (normal free T4), who is currently taking prednisolone 20 mg daily and vitamin D 2000 IU daily, what is the appropriate next management plan?
What is the appropriate management plan for a 58-year-old female with a 17-year history of chronic cough after pneumonia, intermittent sputum production, dyspnea on exertion, nicotine dependence with a 48 pack‑year smoking history (currently smoking ~1 pack every two weeks), who is not on inhalers and requires smoking cessation therapy, a short‑acting bronchodilator inhaler, a 14‑day course of nebulized ipratropium bromide, a cough suppressant, a chest radiograph, and glucose monitoring before a corticosteroid injection?
Can Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) tablets be crushed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.